NCT00853957 - Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension | Biotech Hunter

Enrollment

443

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Hypertension

Interventions

DRUG

Aliskiren/Amlodipine

Aliskiren/Amlodipine 150 mg/5 mg titrated to 300 mg/10 mg

DRUG

Amlodipine

Amlodipine 5 mg titrated to 10mg

Trial Locations (9)

Investigative Site, Chicago

Investigative Site, Baltimore

Investigative Site, Oxon Hill

Investigative Site, Detroit

Investigative Site, Trenton

Investigative Site, Brooklyn

Investigative Site, Springfield Gardens

Investigative Site, Philadelphia

Investigative Site, Milwaukeee